g: Profiler—a web server for functional interpretation of gene lists (2016 update) J Reimand, T Arak, P Adler, L Kolberg, S Reisberg, H Peterson, J Vilo Nucleic acids research 44 (W1), W83-W89, 2016 | 1334 | 2016 |
Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions S Reisberg, K Krebs, M Lepamets, M Kals, R Mägi, K Metsalu, ... Genetics in Medicine 21 (6), 1345-1354, 2019 | 95 | 2019 |
Comparing distributions of polygenic risk scores of type 2 diabetes and coronary heart disease within different populations S Reisberg, T Iljasenko, K Läll, K Fischer, J Vilo PloS one 12 (7), e0179238, 2017 | 79 | 2017 |
Validating Fitbit Zip for monitoring physical activity of children in school: a cross-sectional study K Mooses, M Oja, S Reisberg, J Vilo, M Kull BMC Public Health 18, 1-7, 2018 | 38 | 2018 |
Identifying cases of type 2 diabetes in heterogeneous data sources: strategy from the EMIF project G Roberto, I Leal, N Sattar, AK Loomis, P Avillach, P Egger, ... PloS one 11 (8), e0160648, 2016 | 29 | 2016 |
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis C Yang, RD Williams, JN Swerdel, JR Almeida, ES Brouwer, E Burn, ... Seminars in arthritis and rheumatism 56, 152050, 2022 | 11 | 2022 |
Trajectories: a framework for detecting temporal clinical event sequences from health data standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data Model K Künnapuu, S Ioannou, K Ligi, R Kolde, S Laur, J Vilo, PR Rijnbeek, ... JAMIA open 5 (1), ooac021, 2022 | 9 | 2022 |
An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank G James, S Reisberg, K Lepik, N Galwey, P Avillach, L Kolberg, R Mägi, ... PLoS One 14 (4), e0215026, 2019 | 9 | 2019 |
Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) common data model: Lessons learned M Oja, S Tamm, K Mooses, M Pajusalu, HA Talvik, A Ott, M Laht, M Malk, ... JAMIA open 6 (4), ooad100, 2023 | 7 | 2023 |
Lessons learned during the process of reporting individual genomic results to participants of a population-based biobank L Leitsalu, A Reigo, M Palover, T Nikopensius, K Läll, K Krebs, ... European Journal of Human Genetics 31 (9), 1048-1056, 2023 | 4 | 2023 |
Peptide profiling and monitoring humoral immunity L Kasak, A Kivil, AK Lend, T Neuman, K Palm, A Pihlak, A Alman, ... US Patent 9,672,324, 2017 | 4 | 2017 |
Prevaccination prevalence of type-specific human papillomavirus infection by grade of cervical cytology in Estonia A Uusküla, M Oja, S Tamm, A Tisler, M Laanpere, L Padrik, M Nygard, ... JAMA Network Open 6 (2), e2254075-e2254075, 2023 | 3 | 2023 |
Comparison of variation in frequency for SNPs associated with asthma or liver disease between Estonia, HapMap populations and the 1000 genome project populations S Reisberg, N Galwey, P Avillach, AS Sahlqvist, L Kolberg, R Mägi, ... International Journal of Immunogenetics 46 (2), 49-58, 2019 | 2 | 2019 |
Elektrooniliste terviselugude analüüsimise võimalused Tartu perearstide infosüsteemi näitel S Reisberg, R Sirel, R Kalda, M Merzin, J Pruulmann, J Vilo Eesti Arst, 2013 | 2 | 2013 |
THU0212 FIRST LINE TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: A MULTINATIONAL POPULATION-BASED COHORT FROM 14 REAL … AG Sena, D Granados, N Hughes, W Fakhouri, A Hottgenroth, R Kolde, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 331-331, 2020 | 1 | 2020 |
Eesti eelkooliealiste laste hõlmatus immuniseerimiskava vaktsiinidega 2010. aasta sünnikohordi põhjal Eesti Haigekassa raviarvete alusel S Tamm, E Raie, R Käär, M Oja, S Reisberg Eesti Arst, 2020 | 1 | 2020 |
Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank M Alver, S Kasela, L Haring, LB Luitva, K Fischer, M Möls, L Milani The Lancet Regional Health–Europe 41, 2024 | | 2024 |
Markov modeling for cost-effectiveness using federated health data network M Haug, M Oja, M Pajusalu, K Mooses, S Reisberg, J Vilo, AF Giménez, ... Journal of the American Medical Informatics Association 31 (5), 1093-1101, 2024 | | 2024 |
Vaktsineerimiseelne tüübispetsiifiline inimese papilloomiviiruse levimus emakakaela tsütoloogilise uuringuleiu raskusastme järgi Eestis A Uusküla, M Oja, S Tamm, A Tisler, M Laanpere, L Padrik, M Nygard, ... Eesti Arst, 2024 | | 2024 |
Kroonilise neeruhaiguse levimus Eesti e-tervise andmete alusel M Rosenberg, M Thetloff, S Tamm, K Kuusk, S Reisberg, J Vilo Eesti Arst, 2023 | | 2023 |